Autoimmune Disease Drug Market

Autoimmune Disease Drug Market (Indication - Diabetes Mellitus Type 1, Rheumatic Diseases, Multiple Sclerosis, Rare Diseases, and Other Indication; Drug Class - NSAIDs, Anti-inflammatory, Interferons, Antihyperglycemic, Immunosuppressants, and Other Drug Class; Distribution Channel - Hospital Pharmacies, Online Stores, and Retail Pharmacies): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025

  • Published : October, 2019

  • Rep Id : HC0750

  • Category : Healthcare & Medical Devices

  • Status : Published

Your cart contains following chapters

Chapter Chapter Name Price
Total:
Chapter No. Title/Chapter Name Price
Preface

1.1.   Report Description

1.2.   Research Methods

1.3.   Research Approaches

Free
Executive Summary

2.1.   Autoimmune Disease Drug Market Highlights

2.2.   Autoimmune Disease Drug Market Projection

2.3.   Autoimmune Disease Drug Market Regional Highlights

$250
Global Autoimmune Disease Drug Market Overview

3.1.   Introduction

3.2.   Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3.   Porter's Five Forces Analysis

3.4.   IGR-Growth Matrix Analysis

3.4.1. IGR-Growth Matrix Analysis by Indication

3.4.2. IGR-Growth Matrix Analysis by Drug Class

3.4.3. IGR-Growth Matrix Analysis by Distribution Channel

3.4.4. IGR-Growth Matrix Analysis by Region

3.5.   Value Chain Analysis of Autoimmune Disease Drug Market

$500
Autoimmune Disease Drug Market Macro Indicator Analysis
$250
Global Autoimmune Disease Drug Market by Indication

5.1.   Diabetes Mellitus Type 1

5.2.   Rheumatic Diseases

5.3.   Multiple Sclerosis

5.4.   Rare Diseases

5.5.   Other Indication

$750
Global Autoimmune Disease Drug Market by Drug Class

6.1.   NSAIDs

6.2.   Anti-inflammatory

6.3.   Interferons

6.4.   Antihyperglycemic

6.5.   Immunosuppressants

6.6.   Other Drug Class

$750
Global Autoimmune Disease Drug Market by Distribution Channel

7.1.   Hospital Pharmacies

7.2.   Online Stores

7.3.   Retail Pharmacies

$750
Global Autoimmune Disease Drug Market by Region 2019-2025

8.1.   North America

8.1.1. North America Autoimmune Disease Drug Market by Indication

8.1.2. North America Autoimmune Disease Drug Market by Drug Class

8.1.3. North America Autoimmune Disease Drug Market by Distribution Channel

8.1.4. North America Autoimmune Disease Drug Market by Country

8.2.   Europe

8.2.1. Europe Autoimmune Disease Drug Market by Indication

8.2.2. Europe Autoimmune Disease Drug Market by Drug Class

8.2.3. Europe Autoimmune Disease Drug Market by Distribution Channel

8.2.4. Europe Autoimmune Disease Drug Market by Country

8.3.   Asia-Pacific

8.3.1. Asia-Pacific Autoimmune Disease Drug Market by Indication

8.3.2. Asia-Pacific Autoimmune Disease Drug Market by Drug Class

8.3.3. Asia-Pacific Autoimmune Disease Drug Market by Distribution Channel

8.3.4. Asia-Pacific Autoimmune Disease Drug Market by Country

8.4.   RoW

8.4.1. RoW Autoimmune Disease Drug Market by Indication

8.4.2. RoW Autoimmune Disease Drug Market by Drug Class

8.4.3. RoW Autoimmune Disease Drug Market by Distribution Channel

8.4.4. RoW Autoimmune Disease Drug Market by Sub-region

$2000
Company Profiles and Competitive Landscape

9.1.   Competitive Landscape in the Global Autoimmune Disease Drug Market

9.2.   Companies Profiles

9.2.1. F. Hoffmann-La Roche AG

9.2.2. Abbott Laboratories

9.2.3. Bristol-Myers Squibb Company

9.2.4. Amgen Inc.

9.2.5. Johnson & Johnson

9.2.6. AstraZeneca plc.

9.2.7. Pfizer Inc.

9.2.8. Novartis AG

9.2.9. Other Companies

$1500
Appendix

10.1. Primary Research Findings and Questionnaire

*included in report

Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount